Log In
BCIQ
Print this Print this
 

Granulocyte macrophage colony-stimulating factor (GM-CSF) (CSF2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Granulocyte macrophage colony-stimulating factor (GM-CSF) (CSF2)

BCIQ
Print ChartPrint this
Marketed, 1 Phase II, 1 Phase I/II, 1 Phase I, 1
Phase of DevelopmentPhase IPhase I/IIPhase IIMarketed
Autoimmune

1

-

1

-

Cancer

-

1

-

1




 Products Targeting Granulocyte macrophage colony-stimulating factor (GM-CSF) (CSF2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$742.2M

$42.3M

$549.9M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today